Epidemiologic Impact of Expanding Chronic Hepatitis C (CHC) Treatment in People Who Inject Drug in the United States: A Mathematical Model Using Data From the C-EDGE CO-STAR Study. The Liver Meeting 2017; Washington, DC, USA; October 20-24, 2017 | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Epidemiologic Impact of Expanding Chronic Hepatitis C (CHC) Treatment in People Who Inject Drug in the United States: A Mathematical Model Using Data From the C-EDGE CO-STAR Study. The Liver Meeting 2017; Washington, DC, USA; October 20-24, 2017

Jiang Y, Nwankwo C. Epidemiologic Impact of Expanding Chronic Hepatitis C (CHC) Treatment in People Who Inject Drug in the United States: A Mathematical Model Using Data From the C-EDGE CO-STAR Study. The Liver Meeting 2017; Washington, DC, USA; October 20-24, 2017. 2017.

Publication Type:

Miscellaneous

Authors:

Jiang, Y; Nwankwo, C.

Source:

(2017)

Cited On:

Key Populations: Identification and Management of HCV in People Who Inject Drugs

External Third-party Web Link:

http://www.natap.org/2017/AASLD/AASLD_07.htm

Export Citation:

RIS Format

Top